Yang F E, Brown R S, Koral K F, Clavo A C, Jackson G A, Wahl R L
University of Michigan Medical Center, Department of Internal Medicine, Ann Arbor 48109-0028.
Cancer Immunol Immunother. 1992;35(6):365-72. doi: 10.1007/BF01789014.
We studied the effect of monoclonal antibody protein dose on the uniformity of radioiodinated antibody distribution within tumor masses using quantitative autoradiography. Groups (n = 11-13/group) of athymic nude mice with subcutaneous HTB77 human ovarian carcinoma xenografts were injected intraperitoneally with an 125I-labeled anticarcinoma-associated antigen murine monoclonal antibody, 5G6.4 using a high or a low protein dose (500 micrograms or 5 micrograms). At 6 days post-injection the macroscopic and microscopic intratumoral biodistribution of radiolabeled antibody was determined. The degree of heterogeneity of the labeled antibody distribution within each tumor was quantified and expressed as the coefficient of variation (CV) of the activity levels in serial histological sections. Tumors from mice given the 500-micrograms protein doses had substantially lower CV values, 0.327 +/- 0.027, than did tumors from animals given 5-micrograms protein doses, 0.458 +/- 0.041, (P = 0.0078), indicating that the higher protein dose resulted in more homogeneous distribution of radioactivity in tumors than did the lower dose. While the percentage of the injected dose reaching the tumor was comparable between groups, injecting the higher dose of protein resulted in significantly lower tumor to non-tumor uptake ratios than those obtained for the lower protein dose. These data indicate, in this system, that to achieve more uniform intratumoral antibody (and radiation for radioimmunotherapy) delivery, a relatively high protein dose must be administered. However, to obtain this increased uniformity, a substantial drop in tumor/background uptake ratios was seen. Quantitative autoradiographic evaluation of human tumor xenografts is a useful method to assess the intratumoral distribution of antibodies.
我们使用定量放射自显影技术研究了单克隆抗体蛋白剂量对肿瘤块内放射性碘标记抗体分布均匀性的影响。将皮下接种HTB77人卵巢癌异种移植物的无胸腺裸鼠分为若干组(每组n = 11 - 13),分别腹腔注射高或低蛋白剂量(500微克或5微克)的¹²⁵I标记的抗癌相关抗原鼠单克隆抗体5G6.4。注射后6天,测定放射性标记抗体在肿瘤内的宏观和微观生物分布。对每个肿瘤内标记抗体分布的异质性程度进行量化,并表示为连续组织学切片中活性水平的变异系数(CV)。给予500微克蛋白剂量小鼠的肿瘤CV值显著低于给予5微克蛋白剂量动物的肿瘤,分别为0.327±0.027和0.458±0.041(P = 0.0078),这表明较高的蛋白剂量导致肿瘤内放射性分布比低剂量更均匀。虽然各组间到达肿瘤的注射剂量百分比相当,但注射较高剂量的蛋白导致肿瘤与非肿瘤摄取比值显著低于较低蛋白剂量组。这些数据表明,在该系统中,为了实现更均匀的肿瘤内抗体(以及放射免疫治疗中的辐射)递送,必须给予相对较高的蛋白剂量。然而,为了获得这种增加的均匀性,肿瘤/背景摄取比值出现了大幅下降。对人肿瘤异种移植物进行定量放射自显影评估是评估抗体在肿瘤内分布的一种有用方法。